Kepler Capital Markets Downgrades Arkema (OTCMKTS:ARKAY) to Strong Sell

Arkema (OTCMKTS:ARKAYGet Free Report) was downgraded by investment analysts at Kepler Capital Markets from a “hold” rating to a “strong sell” rating in a report released on Thursday,Zacks.com reports.

Several other equities research analysts also recently weighed in on the stock. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Arkema in a research report on Thursday, April 9th. Sanford C. Bernstein raised shares of Arkema from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Berenberg Bank lowered shares of Arkema from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 20th. The Goldman Sachs Group upgraded shares of Arkema from a “hold” rating to a “buy” rating in a research note on Tuesday, February 10th. Finally, Zacks Research upgraded shares of Arkema from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. Two research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

View Our Latest Stock Analysis on ARKAY

Arkema Price Performance

Shares of ARKAY opened at $74.18 on Thursday. The company has a market capitalization of $5.64 billion, a P/E ratio of 296.71 and a beta of 0.84. The company has a quick ratio of 1.63, a current ratio of 2.13 and a debt-to-equity ratio of 0.54. The firm has a 50 day moving average of $67.95 and a 200 day moving average of $64.26. Arkema has a twelve month low of $56.28 and a twelve month high of $79.36.

Arkema (OTCMKTS:ARKAYGet Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The basic materials company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.10. The company had revenue of $2.57 billion during the quarter, compared to the consensus estimate of $2.52 billion. Arkema had a net margin of 0.46% and a return on equity of 4.06%. As a group, equities research analysts anticipate that Arkema will post 3.79 earnings per share for the current fiscal year.

Arkema Company Profile

(Get Free Report)

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.

Featured Articles

Analyst Recommendations for Arkema (OTCMKTS:ARKAY)

Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.